Expression of programmed death ligand 1 and 2 in adrenocortical cancer tissues: An exploratory study

John F Tierney1, Alyx Vogle1, Jennifer Poirier1

  • 1Rush University Medical Center, Department of Surgery, Division of Surgical Oncology, Chicago, Illinois.

Surgery
|November 11, 2018
PubMed
Abstract

Insights

Programmed death ligand 2 is commonly expressed in adrenocortical carcinoma, unlike programmed death ligand 1. Further studies should evaluate checkpoint inhibitors for this cancer.

Area of Science:

  • Oncology
  • Immunology
  • Cancer Research

Background:

  • Immune checkpoint inhibitors targeting programmed death 1 (PD-1) interactions are effective in advanced cancers.
  • Expression of PD-1 ligands (PD-L1 and PD-L2) has not been previously studied in adrenocortical carcinoma (ACC).

Purpose of the Study:

  • To investigate the expression of programmed death ligand 1 (PD-L1) and programmed death ligand 2 (PD-L2) in adrenocortical carcinoma.
  • To determine the potential utility of immune checkpoint inhibitors in treating ACC.

Main Methods:

  • Analyzed 56 adrenal tissue samples (34 ACC, 22 benign).
  • Utilized immunohistochemistry to detect PD-L1, PD-L2, and CD8 expression.
  • Scored membranous staining and performed statistical analyses (Mann-Whitney U, Fisher exact tests).

Main Results:

  • Programmed death ligand 2 (PD-L2) was expressed in 44% of ACC samples, while PD-L1 expression was found in only one ACC sample (P=.03).
  • ACC samples showed significantly higher PD-L2 expression in tumor or stromal cells compared to benign samples (OR=2.3, P=.03).
  • No significant association was found between PD-L2 expression and CD8 levels or tumor characteristics.

Conclusions:

  • Programmed death ligand 2 (PD-L2) is frequently expressed in adrenocortical carcinoma, suggesting potential therapeutic relevance.
  • Programmed death ligand 1 (PD-L1) expression is rare in ACC.
  • Further research is warranted to evaluate the efficacy of checkpoint inhibitors targeting PD-L1/PD-L2 pathways in ACC treatment.

Related Concept Videos

Predicting Products: SN1 vs. SN202:27

Predicting Products: SN1 vs. SN2

Nucleophilic substitution reactions of alkyl halides can proceed via an SN1 or an SN2 mechanism. While in SN2 reactions, the nucleophile attacks the substrate simultaneously as the leaving group departs, in SN1 reactions, the substrate first dissociates to give the carbocation intermediate. Various factors such as the structure of the substrate, the strength of the nucleophile, and the nature of the solvent promote one mechanism over the other.
With increased substitution on the alkyl halide,...
17.3K
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.1K
Metal-Ligand Bonds02:51

Metal-Ligand Bonds

The hemoglobin in the blood, the chlorophyll in green plants, vitamin B-12, and the catalyst used in the manufacture of polyethylene all contain coordination compounds. Ions of the metals, especially the transition metals, are likely to form complexes.
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
24.3K
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.6K
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Overview01:26

1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Overview

Nitrous acid and nitric acids are two types of acids containing nitrogen, among which nitrous acid is weaker than nitric acid. Nitrous acid with a pKa value of 3.37 ionizes in water to give a nitrite ion and the hydronium ion.
The nitrous acid is unstable. Hence, it is formed in situ from a solution of sodium nitrite and cold aqueous acids such as hydrochloric or sulfuric acid. In an acidic solution, the –OH group of nitrous acid undergoes protonation to give oxonium ion, followed by...
3.9K
1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism01:37

1° Amines to Diazonium or Aryldiazonium Salts: Diazotization with NaNO2 Mechanism

Nitrous acid is a relatively weak and unstable acid prepared in situ by the reaction of sodium nitrite and cold, dilute hydrochloric acid. In an acidic solution, the nitrous acid undergoes protonation when it loses water to form a nitrosonium ion—an electrophile. Nitrous acid reacts with primary amines to give diazonium salts. The reaction is called diazotization of primary amines.
4.9K